RegeneRx Biopharmaceuticals, Inc. (RGRX)
OTCMKTS · Delayed Price · Currency is USD
0.1610
+0.1608 (80,400.00%)
Aug 28, 2025, 8:00 PM EDT
RGRX Market Cap
RGRX has a market cap or net worth of $302.00 as of September 4, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
302.00
Enterprise Value
n/a
Revenue
76.76K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since June 16, 1987, RGRX's market cap has decreased from 58.65M to 302.00, a decrease of -100.00%. That is a compound annual growth rate of -27.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 302.00 | -85.70% |
| Dec 26, 2024 | 2.11K | 16.69% |
| Dec 29, 2023 | 1.81K | -99.99% |
| Dec 30, 2022 | 19.94M | -13.19% |
| Dec 31, 2021 | 22.97M | -61.32% |
| Dec 31, 2020 | 59.38M | 222.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 891.61M |
| Elite Pharmaceuticals | 751.15M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 631.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 394.86M |
| American Oncology Network | 353.52M |